Table 2.

Summarized data on the effectiveness

Endpoints	T0 (range)	T12 (range)	T24 (range)	p
DAS 28	5.3 (4–6.8)	4 (2.1–6.0)	3 (0.5–5.21)	<0.001
Tender joints count	8 (5–18)	5 (1–15)	2 (0–10)	<0.001
Swollen joints counts	3 (1–12)	1 (0–4)	0.5 (0–4)	<0.001
PASI	0.6 (0–5.2)	0.3 (0–4.5)	0.2 (0–2.1)	<0.001
HAQ	1 (0.5–2.62)	0.37 (0.1–2.2)	0.25 (0–1.75)	<0.001
ESR	24 (3–65)	15 (2–86)	9 (2–25)	<0.001
CRP	1.5 (0–36)	0.6 (0–11)	0.3 (0–12)	<0.001
Patients’ VAS	70 (50–90)	50 (30–70)	35 (0–90)	<0.001